Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_assertion type Assertion NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_head.
- NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_assertion description "[We demonstrate that HER2-specific T cells target drug resistant TICs in established OS cell lines, suggesting that incorporating immunotherapy into current treatment strategies for OS has the potential to improve outcomes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_provenance.
- NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_assertion evidence source_evidence_literature NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_provenance.
- NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_assertion SIO_000772 22173710 NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_provenance.
- NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_assertion wasDerivedFrom befree-20150227 NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_provenance.
- NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_assertion wasGeneratedBy ECO_0000203 NP379603.RAt7865KZ3QFdQiyxOsozz20nTsUyvMPy73BxCjPf0Ci8130_provenance.